1. Home
  2. MDWD vs GPRO Comparison

MDWD vs GPRO Comparison

Compare MDWD & GPRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDWD
  • GPRO
  • Stock Information
  • Founded
  • MDWD 2000
  • GPRO 2004
  • Country
  • MDWD Israel
  • GPRO United States
  • Employees
  • MDWD N/A
  • GPRO N/A
  • Industry
  • MDWD Medicinal Chemicals and Botanical Products
  • GPRO Industrial Machinery/Components
  • Sector
  • MDWD Health Care
  • GPRO Consumer Discretionary
  • Exchange
  • MDWD Nasdaq
  • GPRO Nasdaq
  • Market Cap
  • MDWD 184.8M
  • GPRO 193.5M
  • IPO Year
  • MDWD 2014
  • GPRO 2014
  • Fundamental
  • Price
  • MDWD $19.45
  • GPRO $0.97
  • Analyst Decision
  • MDWD Strong Buy
  • GPRO Hold
  • Analyst Count
  • MDWD 1
  • GPRO 1
  • Target Price
  • MDWD $25.00
  • GPRO $1.50
  • AVG Volume (30 Days)
  • MDWD 78.0K
  • GPRO 1.6M
  • Earning Date
  • MDWD 03-20-2025
  • GPRO 02-06-2025
  • Dividend Yield
  • MDWD N/A
  • GPRO N/A
  • EPS Growth
  • MDWD N/A
  • GPRO N/A
  • EPS
  • MDWD N/A
  • GPRO N/A
  • Revenue
  • MDWD $19,720,000.00
  • GPRO $896,011,000.00
  • Revenue This Year
  • MDWD $10.15
  • GPRO N/A
  • Revenue Next Year
  • MDWD $25.62
  • GPRO N/A
  • P/E Ratio
  • MDWD N/A
  • GPRO N/A
  • Revenue Growth
  • MDWD N/A
  • GPRO N/A
  • 52 Week Low
  • MDWD $11.04
  • GPRO $0.89
  • 52 Week High
  • MDWD $24.00
  • GPRO $3.03
  • Technical
  • Relative Strength Index (RSI)
  • MDWD 55.03
  • GPRO 22.61
  • Support Level
  • MDWD $19.59
  • GPRO $1.03
  • Resistance Level
  • MDWD $20.62
  • GPRO $1.04
  • Average True Range (ATR)
  • MDWD 0.83
  • GPRO 0.04
  • MACD
  • MDWD 0.02
  • GPRO -0.01
  • Stochastic Oscillator
  • MDWD 54.60
  • GPRO 0.85

About MDWD MediWound Ltd.

MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds, and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.

About GPRO GoPro Inc.

GoPro Inc is a United States-based company that is principally engaged in designing and providing cameras, mounts, drones and appliances. The company outsources a part of manufacturing to third parties in China. The company sells products across the world through its direct sales channel, which generates over half of total revenue, and indirectly through its distribution channel. The company has presence, including in the Americas, Europe, Middle East, Africa, and Asia-Pacific, with the Americas contributing over half of total revenue.

Share on Social Networks: